PFIZER INC Property, Plant and Equipment, Gross
PFIZER INC (PFE) had Property, Plant and Equipment, Gross of $36.70 billion as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $36.70B.
- 2024-12-31: Property, Plant and Equipment, Gross $34.88B.
- 2023-12-31: Property, Plant and Equipment, Gross $34.98B.
- 2022-12-31: Property, Plant and Equipment, Gross $31.45B.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $36.70B 10-K · filed 2026-02-26 | |
| 2024-12-31 | $34.88B 10-K · filed 2026-02-26 | |
| 2023-12-31 | $34.98B 10-K · filed 2025-02-27 | |
| 2022-12-31 | $31.45B 10-K · filed 2024-02-22 | |
| 2021-12-31 | $29.95B 10-K · filed 2023-02-23 | |
| 2020-12-31 | $28.41B 10-K · filed 2022-02-24 | $28.71B 10-K · filed 2021-02-25 |
| 2019-12-31 | $27.96B 10-K · filed 2021-02-25 | $30.76B 10-K · filed 2020-02-27 |
| 2018-12-31 | $29.98B 10-K · filed 2020-02-27 | |
| 2017-12-31 | $30.04B 10-K · filed 2019-02-28 | |
| 2016-12-31 | $28.13B 10-K · filed 2018-02-22 | |
| 2015-12-31 | $27.27B 10-K · filed 2017-02-23 | |
| 2014-12-31 | $24.99B 10-K · filed 2016-02-29 | |
| 2013-12-31 | $25.68B 10-K · filed 2015-02-27 | |
| 2012-12-31 | $25.96B 10-K · filed 2014-02-28 | $27.88B 10-K · filed 2013-02-28 |
| 2011-12-31 | $29.24B 10-K · filed 2013-02-28 | $30.52B 10-K · filed 2012-02-28 |
| 2010-12-31 | $31.38B 10-K · filed 2012-02-28 | $32.30B 10-K · filed 2011-02-28 |
| 2009-12-31 | $33.92B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |